MyAverix Finance
F · Healthcare
Mabion SA (272)
Biotechnology
Mabion SA (272) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 272
P/E ratio
18.00
Mabion SA (272) — FAQ
What is 272's P/E ratio?
The price-to-earnings (P/E) ratio for Mabion SA (272) is 18.00 (data as of 2026-03-23).
Does Mabion SA pay a dividend?
Dividend yield is not available in the current snapshot for Mabion SA (272). Check the MyAverix Finance app for the latest dividend data.
What sector is Mabion SA in?
Mabion SA (272) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 272 listed on?
272 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.